Arachidonic acid‐derived signaling lipids and functions in impaired healing. Issue 5 (14th September 2015)

• Record Type: Journal Article
• Authors: Dhall, Sandeep; Wijesinghe, Dayanjan Shanaka; Karim, Zubair A.; Castro, Anthony; Vemana, Hari Priya; Khasawneh, Fadi T.; Chalfant, Charles E.; Martins‐Green, Manuela
• Is Part Of: Wound repair and regeneration. Volume 23:Issue 5(2015)
• Page Start: 644
• Page End: 656
• Publication Date: 2015-09-14
• Subjects: Wound healing -- Periodicals; Regeneration (Biology) -- Periodicals; 617.14
• DOI: 10.1111/wrr.12337
• Languages: English
• ISSNs: 1067-1927

Abstract

<abstract abstract-type="main"> <title>ABSTRACT</title> <p>Very little is known about lipid function during wound healing, and much less during impaired healing. Such understanding will help identify what roles lipid signaling plays in the development of impaired/chronic wounds. We took a lipidomics approach to study the alterations in lipid profile in the LIGHT<sup>−/−</sup> mouse model of impaired healing which has characteristics that resemble those of impaired/chronic wounds in humans, including high levels of oxidative stress, excess inflammation, increased extracellular matrix degradation and blood vessels with fibrin cuffs. The latter suggests excess coagulation and potentially increased platelet aggregation. We show here that in these impaired wounds there is an imbalance in the arachidonic acid (AA) derived eicosonoids that mediate or modulate inflammatory reactions and platelet aggregation. In the LIGHT<sup>−/−</sup> impaired wounds there is a significant increase in enzymatically derived breakdown products of AA. We found that early after injury there was a significant increase in the eicosanoids 11‐, 12‐, and 15‐hydroxyeicosa‐tetranoic acid, and the proinflammatory leukotrienes (LTD4 and LTE) and prostaglandins (PGE<sub>2</sub> and PGF<sub>2α</sub>). Some of these eicosanoids also promote platelet aggregation. This led us to examine the levels of other eicosanoids known to be involved in the latter process. We found that thromboxane (TXA<sub>2</sub>/B<sub>2</sub>), and prostacyclins 6kPGF1α are elevated shortly after wounding and in some cases during healing. To determine whether they have an impact in platelet aggregation and hemostasis, we tested LIGHT<sup>−/−</sup> mouse wounds for these two parameters and found that, indeed, platelet aggregation and hemostasis are enhanced in these mice when compared with the control C57BL/6 mice. Understanding lipid signaling in impaired wounds can potentially lead to development of new therapeutics or in using existing nonsteroidal anti‐inflammatory agents to help correct the course of healing.</p> </abstract>